747383
Last Update Posted: 2012-12-05
Recruiting has ended
All Genders accepted | 18 Years-80 Years |
74 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.
The study is aimed at Type 2 Diabetics who are taking Metformin, but whose Diabetes remains poorly controlled. There are two additional medications already in use, Glimepiride and Sitagliptin will be compared to assess levels of improvement in Diabetes control.
Eligibility
Relevant conditions:
Type 2 Diabetes Mellitus
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov